{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:12:35Z","timestamp":1783563155032,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["NIF 12307"],"award-info":[{"award-number":["NIF 12307"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["ECA 2013-2014"],"award-info":[{"award-number":["ECA 2013-2014"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["RFA-2013"],"award-info":[{"award-number":["RFA-2013"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","award":["CIHRPA201309-MP-322414"],"award-info":[{"award-number":["CIHRPA201309-MP-322414"]}],"id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CIHRPA201309-MP-322414"],"award-info":[{"award-number":["CIHRPA201309-MP-322414"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000066","name":"Canadian Child Health Clinician Scientist Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The overall objective of our research is to determine in children with septic shock whether the use of a fluid-sparing strategy results in improved clinical outcomes without an increased risk of adverse events compared to usual care. The specific objective of this pilot randomized controlled trial was to evaluate the feasibility of a definitive multicenter trial to answer our research question.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Pragmatic, 2-arm, parallel group, open-label, prospective pilot randomized controlled trial including a nested biosample-based translational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Pediatric tertiary care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Children aged 29\u00a0days to &lt;18\u00a0years of age presenting to the emergency department or admitted to an inpatient ward (including the PICU) with suspected or confirmed septic shock and a need for ongoing resuscitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Fluid-sparing vs. usual care resuscitation strategy continued until shock reversal. The fluid-sparing intervention comprised instructions to restrict fluid bolus therapy in conjunction with early initiation and\/or preferential use of vasoactive medication support as a strategy to spare fluid while targeting the hemodynamic goals specified in the American College of Critical Care Medicine Surviving Sepsis Guidelines. The usual care strategy did not limit the use of fluid bolus therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and main results<\/jats:title>\n                    <jats:p>\n                      Fifty-three were randomized to usual care (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927) or fluid-sparing (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926). Fifty-one participants were available for primary outcome analysis. Primary feasibility outcomes related to participant enrollment and protocol adherence. Enrollment rate was 1.8 (51\/29); 95% confidence interval [CI]: 1.3\u20132.3 participants\/month. Study procedures were implemented in 49\/51 (96.1%), 95% CI: 86.5\u201399.5% participants within 1\u00a0h of randomization in a median (interquartile range [IQR]) of 8 (5, 15) minutes. The protocol required the use of an exception to consent process and consent for ongoing participation was 48\/51 (94.1%), 95% CI: 83.8\u201398.8%. There were no serious adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We concluded the large multicenter SQUEEZE trial feasible to conduct.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov [NCT01973907]. Registered October 27, 2013,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01973907\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT01973907<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-025-01731-4","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:22:39Z","timestamp":1764332559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The SQUEEZE pilot trial: a trial to determine whether septic shock reversal is quicker in pediatric patients randomized to an early goal directed fluid-sparing strategy vs. usual care"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-9296","authenticated-orcid":false,"given":"Melissa J.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Fox-Robichaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Canadian Critical Care Trials Group and the Canadian Critical Care Translational Biology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"2","key":"1731_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/CCM.0b013e31819323c6","volume":"37","author":"J Brierley","year":"2009","unstructured":"Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37(2):666\u201388. https:\/\/doi.org\/10.1097\/CCM.0b013e31819323c6.","journal-title":"Crit Care Med"},{"issue":"11","key":"1731_CR2","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337. (PubMed PMID: 34605781).","journal-title":"Crit Care Med"},{"issue":"26","key":"1731_CR3","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483\u201395 (PubMed PMID: 21615299).","journal-title":"N Engl J Med"},{"issue":"2","key":"1731_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","volume":"39","author":"JH Boyd","year":"2011","unstructured":"Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259\u201365. https:\/\/doi.org\/10.1097\/CCM.0b013e3181feeb15.","journal-title":"Crit Care Med"},{"issue":"2","key":"1731_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.ccm.0000194725.48928.3a","volume":"34","author":"J-L Vincent","year":"2006","unstructured":"Vincent J-L, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study*. Crit Care Med. 2006;34(2):344\u201353. https:\/\/doi.org\/10.1097\/01.ccm.0000194725.48928.3a.","journal-title":"Crit Care Med"},{"issue":"3","key":"1731_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/PCC.0b013e31822882a3","volume":"13","author":"AA Arikan","year":"2012","unstructured":"Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012;13(3):253\u20138. (PubMed PMID: 21760565).","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"1731_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043953","volume":"7","author":"N Ford","year":"2012","unstructured":"Ford N, Hargreaves S, Shanks L. Mortality after fluid bolus in children with shock due to sepsis or severe infection: a systematic review and meta-analysis. PLoS ONE. 2012;7(8):e43953. https:\/\/doi.org\/10.1371\/journal.pone.0043953.","journal-title":"PLoS ONE"},{"issue":"4","key":"1731_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/cc11466","volume":"16","author":"DJ Dwivedi","year":"2012","unstructured":"Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care. 2012;16(4):R151. https:\/\/doi.org\/10.1186\/cc11466. (PubMedPMID:22889177;PubMedCentralPMCID:3580740).","journal-title":"Crit Care"},{"issue":"8","key":"1731_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000032","volume":"1","author":"PC Liaw","year":"2019","unstructured":"Liaw PC, Fox-Robichaud AE, Liaw KL, McDonald E, Dwivedi DJ, Zamir NM, et al. Mortality risk profiles for sepsis: a novel longitudinal and multivariable approach. Crit Care Explor. 2019;1(8):e0032. https:\/\/doi.org\/10.1097\/CCE.0000000000000032. (Epub 20190801. PubMed PMID: 32166273; PubMed Central PMCID: PMC7063956).","journal-title":"Crit Care Explor"},{"key":"1731_CR10","unstructured":"Consent for research in individual medical emergencies. Chapter 3, Section B, Article 3.8. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. Ottawa, Canada: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada; 2014."},{"issue":"9861","key":"1731_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(12)62160-6","volume":"381","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381(9861):91\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(12)62160-6. (PubMed PMID: 23305999).","journal-title":"Lancet"},{"key":"1731_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586. (PubMedPMID:23303884;PubMedCentralPMCID:PMC3541470).","journal-title":"BMJ"},{"key":"1731_CR13","doi-asserted-by":"publisher","unstructured":"Parker MJ, Thabane L, Fox-Robichaud A, Liaw P, Choong K, Canadian Critical Care Trials G, et al. A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial. Trials. 2016;17(1):556. Epub 20161122. https:\/\/doi.org\/10.1186\/s13063-016-1689-2. PubMed PMID: 27876084; PubMed Central PMCID: PMC5120449.","DOI":"10.1186\/s13063-016-1689-2"},{"key":"1731_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-016-0105-8","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016. https:\/\/doi.org\/10.1186\/s40814-016-0105-8.","journal-title":"Pilot Feasibility Stud"},{"key":"1731_CR15","doi-asserted-by":"publisher","unstructured":"ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371(16):1496\u2013506, https:\/\/doi.org\/10.1056\/NEJMoa1404380. PubMed PMID: 25272316.","DOI":"10.1056\/NEJMoa1404380"},{"key":"1731_CR16","unstructured":"Parker M. SQUEEZE fluid-sparing (intervention) and usual care (control) management strategies. V1 ed. MacSphere2024. Available at: http:\/\/hdl.handle.net\/11375\/29921. Accessed 29 June 2024."},{"key":"1731_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-1","author":"L Thabane","year":"2010","unstructured":"Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010. https:\/\/doi.org\/10.1186\/1471-2288-10-1.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1731_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010. (PubMed PMID: 18929686; PubMed Central PMCID: 2700030).","journal-title":"J Biomed Inform"},{"key":"1731_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jclinepi.2012.09.002","volume":"66","author":"K Cocks","year":"2013","unstructured":"Cocks K, Torgerson D. Sample size calculations for pilot randomized controlled trials: a confidence interval approach. J Clin Epidemiol. 2013;66:197\u2013201.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"1731_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1503\/cmaj.071366","volume":"178","author":"D Cook","year":"2008","unstructured":"Cook D, Lauzier F, Rocha MG, Sayles MJ, Finfer S. Serious adverse events in academic critical care research. CMAJ. 2008;178(9):1181\u20134.","journal-title":"CMAJ"},{"key":"1731_CR21","unstructured":"Hamilton Integrated Research Ethics Board. Instructions for reporting of local and non-local adverse events, version: November 2015_B. (2015). Available at: https:\/\/hireb.ca\/wp-content\/uploads\/2023\/03\/Serious-Adverse-Events-SAE-Unanticipated-Problems.pdf. Accessed 5 Apr 2024."},{"key":"1731_CR22","unstructured":"Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees., OMB Control No. 0910\u20130581 U.S. Department of Health and Human Services Food and Drug Administration. (2006)."},{"key":"1731_CR23","unstructured":"Klabunde R. Cardiovascular physiology concepts: Frank-Starling mechanism: Richard E. Klabunde; 2007 [cited 2025 Aug 15, 2025.]. Available from: http:\/\/www.cvphysiology.com\/Cardiac%20Function\/CF003.htm. Accessed 15 Aug 2025."},{"issue":"7","key":"1731_CR24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","volume":"41","author":"S Leteurtre","year":"2013","unstructured":"Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F. PELOD-2: an update of the PEdiatric logistic organ dysfunction score. Crit Care Med. 2013;41(7):1761\u201373. https:\/\/doi.org\/10.1097\/CCM.0b013e31828a2bbd. (PubMed PMID: 23685639).","journal-title":"Crit Care Med"},{"key":"1731_CR25","doi-asserted-by":"publisher","unstructured":"Shulz KF, Altman DG, Moher D, Group C. Consort 2010 statement: updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol. 2010;63(8):834-40. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.02.005.","DOI":"10.1016\/j.jclinepi.2010.02.005"},{"issue":"8","key":"1731_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2010.03.004","volume":"63","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Shulz KF, Montori V, Gotzsche PC, Deveraux PJ, et al. Consort 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1\u201337. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.004.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1731_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccrj.2024.02.002","volume":"26","author":"MJ Parker","year":"2024","unstructured":"Parker MJ, Foster G, Fox-Robichaud A, Choong K, Mbuagbaw L, Thabane L. Statistical analysis plan for the SQUEEZE trial: a trial to determine whether septic shock reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy vs. usual care (SQUEEZE). Crit Care Resusc. 2024;26(2):123\u201334. https:\/\/doi.org\/10.1016\/j.ccrj.2024.02.002. (Epub 20240622. PubMed PMID: 39072232; PubMed Central PMCID: PMC11282343).","journal-title":"Crit Care Resusc"},{"issue":"5","key":"1731_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/archdischild-2018-314924","volume":"104","author":"DP Inwald","year":"2019","unstructured":"Inwald DP, Canter R, Woolfall K, Mouncey P, Zenasni Z, O\u2019Hara C, et al. Restricted fluid bolus volume in early septic shock: results of the fluids in shock pilot trial. Arch Dis Child. 2019;104(5):426\u201331. https:\/\/doi.org\/10.1136\/archdischild-2018-314924. (Epub 20180807. PubMed PMID: 30087153; PubMed Central PMCID: PMC6557227).","journal-title":"Arch Dis Child"},{"issue":"2","key":"1731_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/PCC.0000000000003351","volume":"25","author":"A Harley","year":"2024","unstructured":"Harley A, George S, Phillips N, King M, Long D, Keijzers G, et al. Resuscitation with early adrenaline infusion for children with septic shock: a randomized pilot trial. Pediatr Crit Care Med. 2024;25(2):106\u201317. https:\/\/doi.org\/10.1097\/PCC.0000000000003351. (Epub 20240119. PubMed Central PMCID: PMC10798589).","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"1731_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/PCC.0000000000000558","volume":"17","author":"MM Pollack","year":"2016","unstructured":"Pollack MM, Holubkov R, Funai T, Dean JM, Berger JT, Wessel DL, et al. The pediatric risk of mortality score: update 2015. Pediatr Crit Care Med. 2016;17(1):2\u20139. https:\/\/doi.org\/10.1097\/PCC.0000000000000558. (PubMed PMID: 26492059; PubMed Central PMCID: PMC5048467).","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"1731_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012931","volume":"6","author":"MJ Parker","year":"2016","unstructured":"Parker MJ, de Laat S, Schwartz L. Exploring the experiences of substitute decision-makers with an exception to consent in a paediatric resuscitation randomised controlled trial: study protocol for a qualitative research study. BMJ Open. 2016;6(9):e012931. https:\/\/doi.org\/10.1136\/bmjopen-2016-012931. (Epub 20160913. PubMed PMID: 27625066; PubMed Central PMCID: PMC5030536).","journal-title":"BMJ Open"},{"key":"1731_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2809","volume":"344","author":"EA Akl","year":"2012","unstructured":"Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ. 2012;344:e2809. https:\/\/doi.org\/10.1136\/bmj.e2809. (Epub 20120518. PubMed PMID: 22611167).","journal-title":"BMJ"},{"issue":"4","key":"1731_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/1740774515588097","volume":"12","author":"LN Yelland","year":"2015","unstructured":"Yelland LN, Sullivan TR, Voysey M, Lee KJ, Cook JA, Forbes AB. Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clin Trials. 2015;12(4):418\u201323. https:\/\/doi.org\/10.1177\/1740774515588097. (Epub 20150601. PubMed PMID: 26033877; PubMed Central PMCID: PMC4509880).","journal-title":"Clin Trials"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01731-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:22:43Z","timestamp":1764332563000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01731-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01731-4","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for single-center study conduct was granted by the Hamilton Integrated Research Ethics Board (HIREB) on June 4, 2013 (Project ID: 13-295). As a trial which enrolled participants experiencing an individual medical emergency, the research ethics board approved protocol included the use of an exception to consent (deferred consent) process as supported by the Canadian Tri-council policy statement guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}